Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 · After $185M asset buy, Merz Therapeutics plots US workforce expansion as CEO eyes more deals. Freshly equipped with two approved meds from Acorda Therapeutics, …
Merz Enters Asset Purchase Agreement With a US-Based Biotech …
Apr 2, 2024 · FRANKFURT AM MAIN, Germany, April 02, 2024 -- (BUSINESS WIRE)-- Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered into an Asset Purchase …
Merz Therapeutics Closes $185M Asset Purchase Agreement with …
Jul 10, 2024 · The completion of this deal, valued at USD 185 million in cash, bolsters Merz Therapeutics’ market position by enhancing offerings for people living with Parkinson’s …
Merz Therapeutics Closes $185M Asset Purchase Agreement with …
Jul 10, 2024 · Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics. Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA …
News - Merz Pharma
Mar 1, 2023 · Merz enters Asset Purchase Agreement with a US-based biotech company. Second investment in a NASDAQ company in just over ten years. Frankfurt am Main, Germany / April …
UPDATED: Acorda inks $185M asset sale to Merz, files for ...
Apr 9, 2024 · Germany’s Merz therapeutics, known for its Botox rival Xeomin, has stepped in to pick up the company’s Parkinson’s disease med Inbrija and multiple sclerosis drug Amprya (or …
Acorda Therapeutics Inc - Acorda Therapeutics and Merz …
Apr 1, 2024 · PEARL RIVER, N.Y.-- (BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) (“Acorda” or “the Company”) today announced that it has entered into an asset …
Acorda Therapeutics and Merz Announce Signing of "Stalking …
Apr 1, 2024 · Acorda Files for Voluntary Chapter 11 Protection to Facilitate Orderly Sale. Acorda Enters into a Restructuring Support Agreement with over 90% of the Secured Convertible …
News & Press releases | Merz Therapeutics - North America (US)
Jul 30, 2024 · Merz Therapeutics Closes $185M Asset Purchase... Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA (fampridine) expands specialty neurology …
News & Press releases | Merz Therapeutics
Oct 24, 2024 · Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, received approval from Swissmedic, the national authorization and supervisory …